|
| Acusphere Submits New Drug Application for FDA Approval of Imagify(TM) |
29 Apr 08, 16:54 |
|
| Acusphere Inc. (NASDAQ: ACUS) announced today the submission of a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for approval to market its lead product candidate, Imagify(TM) (Perflubutane Polymer Microspheres for Injectable Suspension). Imagify is an ultrasound imaging agent for the detection of coronary artery disease, the leading cause of death in the United States. ... |
| more |
|
